Company Filing History:
Years Active: 2024
Title: Ash Bahl: Innovator in Therapeutic Compounds
Introduction
Ash Bahl is a notable inventor based in Dublin, Ireland. She has made significant contributions to the field of therapeutic compounds, particularly in the development of CDK inhibitors. Her work is aimed at addressing various disorders through innovative pharmaceutical solutions.
Latest Patents
Ash Bahl holds a patent for her invention titled "4-[[[7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors." This patent focuses on certain APPAMP compounds that selectively inhibit cyclin-dependent kinases (CDKs). The invention is relevant for treating a range of disorders, including cancer, viral infections, neurodegenerative diseases, and autoimmune disorders.
Career Highlights
Ash Bahl is currently associated with Carrick Therapeutics Limited, where she continues to advance her research in therapeutic compounds. Her innovative approach has positioned her as a key player in the pharmaceutical industry.
Collaborations
Ash collaborates with esteemed colleagues, including Ed Ainscow and Alexander Bondke, to further her research and development efforts in the field of therapeutics.
Conclusion
Ash Bahl's contributions to the development of CDK inhibitors highlight her role as an influential inventor in the pharmaceutical industry. Her work continues to pave the way for innovative treatments for various medical conditions.